Increase in serum haptoglobin and apolipoprotein M in patients with obstructive sleep apnoea

Journal of Sleep Research

Volumn 18, Issue 3, 2009, Pages 313-320

  Kim, Jinkwan ^a,b   Lee, Seunggwan ^b   In, Kwangho ^a   Kim, Jehyeong ^a   You, Sehwa ^a   Kang, Kyungho ^a   Sim, Jaejeong ^a   Lee, Sangyeub ^a   Yoon, Daewui ^b   Lee, Jungbok ^b   Shin, Chol ^a,b  

^a Korea University Ansan Hospital   (South Korea)

^b Korea University   (South Korea)

Author keywords

Apolipoprotein M; Haptoglobin; Obstructive sleep apnoea; Paraoxonase 1; Proteomics; Serum

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN M; ARYLDIALKYLPHOSPHATASE 1; HAPTOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; SLEEP APNEA SYNDROME; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; APOLIPOPROTEINS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROTEOMICS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 69049100291     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2008.00725.x     Document Type: Article

References (42)

1. Ahmed, Z., Babaei, S., Maguire, G. F., Draganov, D., Kuksis, A., La Du, B. N. and Connelly, P. W. Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine. Cardiovasc. Res., 2003, 57: 225-231.
2. American Sleep Disorders Association. EEG arousals: scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the American Sleep Disorders Association. Sleep, 1992, 15: 173-184.
3. Anderson, N. L. and Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics, 2002, 1: 845-867.
4. Arumugam, T. V., Magnus, T., Woodruff, T. M., Proctor, L. M., Shiels, I. A. and Taylor, S. M. Complement mediators in ischemia-reperfusion injury. Clin. Chim. Acta, 2006, 374: 33-45.
5. Atwood, C. W. Sleep-related hypoventilation: the evolving role of leptin. Chest, 2005, 128: 1079-1081.
6. Calvo, K. R., Liotta, L. A. and Petricoin, E. F. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci. Rep., 2005, 25: 107-125.
7. Charlton-Menys, V., Liu, Y. and Durrington, P. N. Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate. Clin. Chem., 2006, 52: 453-457.
8. Cho, N., Joo, S., Kim, J., Abbott, R. D., Kim, J., Kimm, K. and Shin, C. Relation of habitual snoring with components of metabolic syndrome in Korean adults. Diabetes Res. Clin. Pract., 2006, 71: 256-263.
9. Cid, M. C., Grant, D. S., Hoffman, G. S., Auerbach, R., Fauci, A. S. and Kleinman, H. K. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J. Clin. Invest., 1993, 91: 977-985.
10. Duncan, M. W. and Hunsucker, S. W. Proteomics as a tool for clinically relevant biomarker discovery and validation. Exp. Biol. Med. (Maywood), 2005, 230: 808-817.
11. Durrington, P. N., Mackness, B. and Mackness, M. I. Paraoxonase polymorphisms and coronary heart disease. Lancet, 2004, 364: 579-580. Author reply 580.
12. Engström, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L. and Lindgärde, F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation, 2002, 105: 2632-2637. (Pubitemid 34596040)
13. Engström, G., Hedblad, B., Stavenow, L., Tydén, P., Lind, P., Janzon, L. and Lindgärde, F. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation, 2004, 110: 27-31. (Pubitemid 38880130)
14. Granger, J., Siddiqui, J., Copeland, S. and Remick, D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics, 2005, 5: 4713-4718. (Pubitemid 43016893)
15. Hanash, S. M., Madoz-Gurpide, J. and Misek, D. E. Identification of novel targets for cancer therapy using expression proteomics. Leukemia, 2002, 16: 478-485. (Pubitemid 34449727)
16. Hortin, G. L., Jortani, S. A., Ritchie, J. C. Jr, Valdes, R. Jr and Chan, D. W. Proteomics: a new diagnostic frontier. Clin. Chem., 2006, 52: 1218-1222.
17. Jungblut, P. R., Zimny-Arndt, U., Zeindl-Eberhart, E., Stulik, J., Koupilova, K., Pleissner, K. P., Otto, A., Müller, E. C., Sokolowska-Köhler, W., Grabher, G. and Stöffler, G. Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis, 1999, 20: 2100-2110. (Pubitemid 29376818)
18. Kim, J., In, K., Kim, J., You, S., Kang, K., Shim, J., Lee, S., Lee, J., Lee, S., Park, C. and Shin, C. Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am. J. Respir. Crit. Care Med., 2004, 170: 1108-1113.
19. Langlois, M. R. and Delanghe, J. R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem., 1996, 42: 1589-1600.
20. Lavie, L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med. Rev., 2003, 7: 35-51.
21. Lavie, L., Lotan, R., Hochberg, I., Herer, P., Lavie, P. and Levy, A. P. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep, 2003, 26: 592-595. (Pubitemid 39610652)
22. Lavie, L., Vishnevsky, A. and Lavie, P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep, 2004, 27: 123-128. (Pubitemid 43906323)
23. Luo, G., Zhang, X., Nilsson-Ehle, P. and Xu, N. Apolipoprotein M. Lipids Health Dis., 2004, 3: 21.
24. Mackness, B., Durrington, P. N. and Mackness, M. I. Human serum paraoxonase. Gen. Pharmacol., 1998, 31: 329-336.
25. Ohga, E., Nagase, T., Tomita, T., Teramoto, S., Matsuse, T., Katayama, H. and Ouchi, Y. Increased levels of circulating ICAM-1, VCAM-1, and I-selectin in obstructive sleep apnea syndrome. J. Appl. Physiol., 1999, 87: 10-14.
26. Phillips, B. G., Narkiewicz, K., Pesek, C. A., Haynes, W. G., Dyken, M. E. and Somers, V. K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J. Hypertens., 1999, 17: 61-66. (Pubitemid 29086189)
27. Polotsky, V. Y. and O'Donell, C. P. Genomics of sleep-disordered Breathing. Proc. Am. Thorac. Soc., 2007, 4: 121-126.
28. Punjabi, N. M., Shahar, E., Redline, S., Gottlieb, D. J., Givelber, R. and Resnick, H. E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol., 2004, 160: 521-530.
29. Rechtschaffen, A. and Kales, A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. NIH Publication No. 204. US Government Printing Office, Washington, DC, 1968.
30. Shahar, E., Whitney, C. W., Redline, S., Lee, E. T., Newman, A. B., Javier Nieto, F., O'Connor, G. T., Boland, L. L., Schwartz, J. E. and Samet, J. M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am. J. Respir. Crit. Care Med., 2001, 163: 19-25.
31. Shevchenko, A., Wilm, M., Vorm, O. and Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 1996, 68: 850-858.
32. Shin, C., Kim, J., Kim, J., Lee, S., Shim, J., In, K., Kang, K., Yoo, S., Cho, N., Kimm, K. and Joo, S. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am. J. Respir. Crit. Care Med., 2005, 171: 287-291.
33. Suzuki, Y. J., Jain, V., Park, A. M. and Day, R. M. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic. Biol. Med., 2006, 40: 1683-1692.
34. Tatsumi, K., Kasahara, Y., Kurosu, K., Tanabe, N., Takiguchi, Y. and Kuriyama, T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest, 2005, 127: 716-721. (Pubitemid 40775497)
35. Wagner, L., Gessl, A., Parzer, S. B., Base, W., Waldhäusl, W. and Pasternack, M. S. Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J. Immunol., 1996, 156: 1989-1996.
36. Westfall, P. and Young, S. Resampling-based Multiple Testing: Examples and Methods for P-value Adjustment. John Wiley & Sons, London, 1993.
37. Xu, N., Zhang, X. Y., Dong, X., Ekström, U., Ye, Q. and Nilsson-Ehle, P. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. Biochem. Biophys. Res. Commun., 2002, 292: 944-950.
38. Xu, N., Nilsson-Ehle, P. and Ahren, B. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. J. Nutr. Biochem., 2004, 15: 579-582.
39. Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M. and Mohsenin, V. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med., 2005, 353: 2034-2041.
40. Yokoe, T., Minoguchi, K., Matsuo, H., Oda, N., Minoguchi, H., Yoshino, G., Hirano, T. and Adachi, M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003, 107: 1129-1134. (Pubitemid 36297204)
41. Young, T., Peppard, P. E. and Gottlieb, D. J. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med., 2002, 165: 1217-1239.
42. Zhang, X. Y., Dong, X., Zheng, L., Luo, G. H., Liu, Y. H., Ekström, U., Nilsson-Ehle, P., Ye, Q. and Xu, N. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem., 2003, 105: 67-72. (Pubitemid 36313933)